Text Size

Evaluation of Patients With Idiopathic Pulmonary Fibrosis (IPF) Through an IPF Registry

This study is currently recruiting participants.
Verified June 2012 by New York University School of Medicine
Sponsor:
Information provided by (Responsible Party):
Rany Condos, MD, New York University School of Medicine
ClinicalTrials.gov Identifier:
NCT00212511
First received: September 13, 2005
Last updated: June 20, 2012
Last verified: June 2012
History of Changes
  Purpose

The purpose of this study is to create a database of demographics and samples in idiopathic pulmonary fibrosis.


Condition
Idiopathic Pulmonary Fibrosis

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Prospective Evaluation of Patients With Idiopathic Pulmonary Fibrosis Through an IPF Registry

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by New York University School of Medicine:

Estimated Enrollment: 50
Study Start Date: November 2004
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients with interstitial lung disease.

Criteria

Inclusion Criteria:

  • IPF diagnosis by ATJ criteria or by tissue biopsy
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00212511

Contacts
Contact: Rany Condos, MD (212)263-7951 Rany.Condos@nyumc.org

Locations
United States, New York
NYU School of Medicine Recruiting
New York, New York, United States, 10016
Contact: Sue Chow     212-263-6411        
Principal Investigator: Rany Condos, MD            
Sponsors and Collaborators
New York University School of Medicine
Investigators
Principal Investigator: Rany Condos, MD NYU School of Medicine, Division of Pulmonary and Critical Care Medicine
  More Information

No publications provided

Responsible Party: Rany Condos, MD, Assistant Professor of Medicine, New York University School of Medicine
ClinicalTrials.gov Identifier: NCT00212511     History of Changes
Other Study ID Numbers: 10386-02 A
Study First Received: September 13, 2005
Last Updated: June 20, 2012
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Fibrosis
Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
Pathologic Processes
 Lung Diseases
Respiratory Tract Diseases
Idiopathic Interstitial Pneumonias
Lung Diseases, Interstitial

ClinicalTrials.gov processed this record on May 16, 2013